Cargando…
Development and validation of prognostic nomograms and a web-based survival rate calculator for sarcomatoid renal cell carcinoma in pre- and post-treatment patients
BACKGROUND: To develop a clinical prediction model and web-based survival rate calculator to predict the overall survival (OS) and cancer-specific survival (CSS) of sarcomatoid renal cell carcinoma (SRCC) for clinical diagnosis and treatment. METHODS: SRCC patient data were retrieved from Surveillan...
Autores principales: | Yang, Tong, Wu, Yaohai, Zuo, You, Fu, Shuai, Xu, Zhonghua, Yu, Nengwang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947429/ https://www.ncbi.nlm.nih.gov/pubmed/33718077 http://dx.doi.org/10.21037/tau-20-1192 |
Ejemplares similares
-
Propensity-score matched comparison of partial versus radical nephrectomy for T1N0M0 sarcomatoid renal cell carcinoma
por: Ji, Bing, et al.
Publicado: (2020) -
A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database
por: Ji, Bing, et al.
Publicado: (2020) -
Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022) -
Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy
por: Zhang, Zhao, et al.
Publicado: (2020) -
A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma
por: Wu, Yijian, et al.
Publicado: (2023)